News
|2 min read
Executive War College Organizer Offers Five Predictions Stemming from the Event
Conference producer Ashleigh Harris had a front-row seat to planning calls, content development, and speaker feedback
|2 min read
New Blood Test Detects Testicular Cancers Missed by Standard Markers
Mayo Clinic researchers have developed two new blood tests that use immune system signals to improve detection and classification of testicular germ cell tumors
|2 min read
The 10-Minute Window: Fentanyl Testing Moves to the Front Lines
As synthetic opioids saturate the clinical landscape, Labcorp’s new FDA-cleared rapid test offers emergency teams a 10-minute lifeline in the race against overdose
|3 min read
Labcorp, CHOP Partner to Expand Access to Pediatric Diagnostics Nationwide
The partnership focuses on accelerating development of pediatric diagnostics across rare disease, oncology, and metabolic conditions
|2 min read
Researchers Analyze the Performance of GIFT, a Web-Based Cascade Testing Portal that Clinical Labs Could Use
With more than 250,000 cancer patients undergoing genetic testing this year, researchers are turning to web portals and AI to manage family notifications
|2 min read
Mayo Clinic, Stanford Develop Blood Test to Predict Immunotherapy Response
The liquid biopsy uses cell-free DNA to map tumor microenvironments, helping identify which patients may benefit from immunotherapy across multiple cancer types
|2 min read
FDA Launches Initiative to Advance Drug Repurposing for Unmet Medical Needs
The agency is particularly focused on new uses to treat chronic or rare diseases, substance use disorders
|2 min read
Roche to Acquire PathAI in a Move to Solve the Digital Pathology Integration Puzzle
By absorbing PathAI’s AISight platform, Roche aims to eliminate vendor fatigue for clinical labs and high capital hurdles that have slowed clinical adoption of AI-powered diagnostics
|2 min read
Vanderbilt Researchers Leverage Liquid Biopsies to Predict Immunotherapy Response in High-Risk Breast Cancer Patients
New study utilizes RNA sequencing of peripheral blood to monitor T-cell activity, offering a potential alternative to invasive tissue biopsies for clinical laboratories and oncologists
|2 min read
Blood-Based RNA Biomarkers Identified for Inflammatory Breast Cancer in Liquid Biopsy Study
Researchers identify RNA-based blood biomarkers for inflammatory breast cancer using TGIRT sequencing, suggesting a potential noninvasive tool for diagnosis and disease monitoring
Updated |2 min read
Thermo Fisher to Divest Microbiology Business to Astorg for $1.1 Billion
Private equity firm Astorg to acquire Thermo Fisher’s AST and culture media unit as the medtech giant sharpens its specialty diagnostics portfolio
|2 min read
